metricas
covid
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Respuesta favorable a la colchicina en la amiloidosis secundaria a la enfermedad...
Journal Information
Vol. 24. Issue 4.
Pages 196-198 (January 2001)
Share
Share
Download PDF
More article options
Vol. 24. Issue 4.
Pages 196-198 (January 2001)
Full text access
Respuesta favorable a la colchicina en la amiloidosis secundaria a la enfermedad inflamatoria intestinal
Good Response to Colchicine in Amyloidosis Secondary to Inflammatory Bowel Disease
Visits
8024
A. Garrido Serranoa,*, F.J. Guerrero Igeab, C. Hierro Guilmainc, E. Ruiz Lupiañezd, S. Palomo Gilád
a Unidad de Digestivo. Servicios de. Hospital Comarcal de Riotinto. Huelva
b Medicina Interna. Hospital Comarcal de Riotinto. Huelva
c Anatomía Patológica. Hospital Comarcal de Riotinto. Huelva
d Cirugía General. Hospital Comarcal de Riotinto. Huelva
This item has received
Article information
Resumen

La amiloidosis sistémica adquirida puede aparecer durante el curso de numerosas enfermedades inflamatorias crónicas, incluyendo la enfermedad inflamatoria intestinal. Aunque la amiloidosis es una complicación relativamente rara, puede resultar fatal, en especial cuando afecta a los riñones, por lo que resulta importante su diagnóstico, más aún teniendo en cuenta la posibilidad de tratamiento con colchicina.

Presentamos el caso de una mujer de 25 años de edad, diagnosticada de enfermedad de Crohn desde los 13 años, con afección del íleon terminal y del colon derecho, que precisó intervención quirúrgica por una actividad inflamatoria que no respondía a tratamiento médico con esteroides e inmunosupresores, y que con posterioridad presentó síndrome nefrótico debido a infiltración por amiloide que evolucionó favorablemente al instaurar tratamiento con colchicina.

Abstract

Acquired systemic amyloidosis may develop during the course of a number of chronic inflammatory diseases, including inflammatory bowel disease. Amyloidosis, although rare, is life-threatening, especially when it involves the kidneys. It is important to recognize this complication, especially since colchicine has been proposed as a possible treatment.

We present a 25-year-old female diagnosed at the age of 13 years with Crohn's disease with involvement of the terminal ileum and right colon. Surgery was performed because of inflammatory activity unresponsive to corticosteroid and immunosuppressive drugs. She subsequently presented nephrotic syndrome due to secondary amyloidosis, which responded well to colchicine treatment.

Full text is only aviable in PDF
Bibliografía
[1.]
G.C. Glenner.
Amyloid deposits and amyloidosis.
N Engl J Med, 302 (1980), pp. 1283-1292
[2.]
A.J. Greenstein, H.D. Janowitz, D.B. Sachar.
The extraintestinal manifestations of Crohn's disease and ulcerative colitis: a study of 700 patients.
Medicine, 55 (1976), pp. 401-409
[3.]
O. Fausa, K. Nygaard, K. Elgio.
Amyloidosis and Crohn's disease.
Scand J Gastroenterol, 12 (1977), pp. 657-663
[4.]
P. Mandelstam, D.E. Simmons, B. Mitchell.
Regression of amyloid in Crohn's disease after bowel resection: a 19-year follow up.
J Clin Gastroenterol, 11 (1989), pp. 324-329
[5.]
S. Myers, H.D. Janowitz, W. Gumarte.
Colchicine therapy of the renal amyloidosis of ulcerative colitis.
Gastroenterology, 94 (1988), pp. 503-509
[6.]
A.J. Greenstein, D.B. Sachar, K. Aditya, N. Panday, S.H. Dikman, S. Meyers, et al.
Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients.
Medicine, 71 (1992), pp. 261-270
[7.]
P. Sánchez Creus, J. Martínez López de Letona, J.M. Ladero Quesada, G. Gilsanz Rico.
Glycogenosis type III and Crohn's disease with associated ankylopoietic spondylitis and secondary amyloidosis. An unusual coincidence.
An Med Intern, 11 (1994), pp. 591-594
[8.]
F.J. Cerdán, M. Díez, C. Pérez de Oteiza, S. Martínez, F. Hernández Merlo, J.L. Balibrea.
Renal amyloidosis in a case of Crohn's disease with colonic and rectal involvement.
Rev Esp Enferm Digest, 80 (1991), pp. 123-126
[9.]
J.L. Sánchez Lombrana, A. Trivino, A. Linares, C.A. Navascues, R. Pérez, M. Rodríguez, et al.
Crohn's disease and amyloidosis. An association to be considered.
Rev Esp Enferm Digest, 80 (1991), pp. 337-341
[10.]
D. Tovbin, L. Kachko, N. Hilzenrat.
Severe interstitial nephritis in a patient with renal amyloidosis and exacerbation of Crohn's disease.
Clin Nephrol, 53 (2000), pp. 147-151
[11.]
L. Larvol, J.P. Cervoni, M. Bernier, L. Dupuoet, H. Beaufils, J.P. Clauvel, et al.
Reversible nephrotic syndrome in Crohn's disease complicated with renal amyloidosis.
Gastroenterol Clin Biol, 22 (1998), pp. 639-641
[12.]
F.C. Edwards, S.C. Truelove.
The course and prognosis of ulcerative colitis.
Gut, 5 (1964), pp. 1-22
[13.]
J.A. Rand, L.J. Brandt, N.H. Becker, J. Lynch.
Ulcerative colitis complicated by amyloidosis.
Am J Gastroenterol, 26 (1979), pp. 513-515
[14.]
S. Myers, H.D. Janowitz, V.V. Gumarte, R.G. Abramson, L.J. Barman, V.S. Venkataseshan, et al.
Colchicine therapy of the renal amyloidosis of ulcerative colitis.
Gastroenterology, 94 (1988), pp. 1503-1507
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos